REG - Inspiration Health - Grant of Options under Sharesave Scheme

Inspiration HealthcareAnnouncement

09/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240409:nRSI7533Ja&default-theme=true

RNS Number : 7533J  Inspiration Healthcare Group PLC  09 April 2024

9 April 2024

Inspiration Healthcare Group plc

("Inspiration Healthcare" or the "Company")

 

Grant of Options under Sharesave Scheme

Inspiration Healthcare Group plc (AIM: IHC), the global medical device
company, announces that it has granted a total of 318,730  options over
ordinary shares of 10 pence each in the capital of the Company ("Options") on
28 March 2024, under the Company's Sharesave Scheme (the "Scheme"), including
a total of 5,225 Options to one Person Discharging Managerial Responsibilities
("PDMRs") as detailed below.

The Scheme is available to all employees subject to qualifying conditions. The
Scheme was introduced to encourage wider employee share ownership of the
Company. The Options are exercisable after three years at an exercise price of
28.4 pence, being a 20 per cent. discount to the closing price on 5 March
2024.

For further information:

 Inspiration Healthcare Group plc                                                Tel: +44 (0)330
                                                 175 0000
 Neil Campbell, Chief Executive Officer

 Alan Olby, Chief Financial Officer

 Liberum (Nominated Adviser & Broker)                                            Tel: +44 (0)20
                                                 3100 2000
 Phil Walker

 Richard Lindley

 Walbrook PR Ltd (Media and Investor Relations)  Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
                                                 (mailto:inspirationhealthcare@walbrookpr.com)
 Anna Dunphy                                     Mob: +44 (0) 7876 741 001
 Stephanie Cuthbert                              Mob: +44 (0) 7796 794 663
 Louis Ashe-Jepson                               Mob: +44 (0) 7747 515 393

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1     Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         Annabelle Ball

 2     Reason for the notification
 a)    Position/status                                              PDMR

 b)    Initial notification /Amendment                              Initial
 3     Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Inspiration Healthcare Group plc

 b)    LEI                                                          213800GKFT3ENAPMDL15

 4     Details of the transaction(s): section to be repeated for (i) each type of

     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the financial instrument, type of instrument  Options over Ordinary Shares of 10p each in the capital of the Company

       Identification code                                          ISIN: GB00BXDZL105
 b)    Nature of the transaction                                    Grant of Options under the Company's Sharesave Scheme
 c)    Price(s) and volume(s)                                       Price(s)             Volume(s)

                                                            1.    28.4 pence     1.    5,225

 

 d)    Aggregated information

       - Aggregated volume

N/A - single transaction
       - Price

 e)    Date of the transaction                                      28 March 2024
 f)    Place of the transaction                                     Outside of a trading venue

 

 

d)

 

Aggregated information

- Aggregated volume

- Price

 

 

N/A - single transaction

 

e)

Date of the transaction

28 March 2024

f)

Place of the transaction

Outside of a trading venue

 

About Inspiration Healthcare

 

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.

 

The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.

 

The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy.  In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.

 

The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and from its facility in Hailsham,
East Sussex, and in the USA from its facility in Melbourne, Florida.

 

Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHGZGGDNRMGDZM